BMRN — Biomarin Pharmaceutical Inc

AI Signal & Stock Analysis · Very Strong ↑

As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for BMRN is Very Strong ↑; the stock is at $67.44 (-1.58% today); neutral (RSI 66); technical trend is Raise; news sentiment is positive.

Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.

Key metrics

What's driving the signal

• RSI is neutral
• Relative volume 0.34× (light)
• Technical trend is Raise
• News sentiment is positive
• 5% below its 52-week high
• 37% above its 52-week low

Frequently asked about BMRN

What is AkshayaAI's signal for BMRN today?

As of Aug 14 2026, 1:04 PM, AkshayaAI assigns BMRN (Biomarin Pharmaceutical Inc) a Very Strong signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.

Is BMRN overbought or oversold right now?

BMRN's RSI is neutral (RSI 66). A reading above 70 is typically considered overbought and below 30 oversold.

Where is BMRN in its 52-week range?

BMRN is trading about 5% below its 52-week high and 37% above its 52-week low as of Aug 14 2026, 1:04 PM.

When is BMRN's next earnings date?

BMRN's next earnings date is 8/6/2026 4:30:00 PM.

What sector is BMRN in?

BMRN is classified under Healthcare-Genetherapy in AkshayaAI's taxonomy.

AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.